SEARCH

SEARCH BY CITATION

References

  • 1
    Carmel R. Subtle and atypical cobalamin deficiency states. Am J Hematol 1990; 34: 10814.
  • 2
    Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore) 1991; 70: 22945.
  • 3
    Martin DC, Francis J, Protetch J, Huff J. Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 1992; 40: 16872.
  • 4
    Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol 1990; 34: 99107.
  • 5
    England JM, Linnell JC. Problems with the serum vitamin B12 assay. Lancet 1980; ii: 10723.
  • 6
    Herbert V, Colman N, Palat D et al. Is there a ‘‘gold standard’’ for human serum vitamin B12 assay? J Lab Clin Med 1984; 104: 82941.
  • 7
    Schilling RF. Who has vitamin B12 deficiency? Proceedings of the Association of American Physicians 1996; 108: 6870.
  • 8
    Carmel R. Current concepts in cobalamin deficiency. Annu Rev Med 2000; 51: 35775.
  • 9
    Hvas AM, Ellegaard J, Nexø E. Vitamin B-12 treatment normalizes metabolic markers but has limited clinical effect: a randomized placebo-controlled study. Clin Chem 2001; 47: 1396404.
  • 10
    Rasmussen K, Vyberg B, Pedersen KO, Brochner-Mortensen J. Methylmalonic acid in renal insufficiency: evidence of accumulation and implications for diagnosis of cobalamin deficiency. Clin Chem 1990; 36: 15234.
  • 11
    Hvas AM, Juul S, Gerdes LU, Nexø E. The marker of cobalamin deficiency, plasma methylmalonic acid, correlates to plasma creatinine. J Intern Med 2000; 247: 50712.
  • 12
    Hultberg B, Andersson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol 1993; 40: 2305.
  • 13
    Joosten E, van den Berg A, Riezler R et al. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. Am J Clin Nutr 1993; 58: 46876.
  • 14
    Herzlich B, Herbert V. Depletion of serum holotranscobalamin II. An early sign of negative vitamin B12 balance. Lab Invest 1988; 58: 3327.
  • 15
    Herbert V, Fong W, Gulle V, Stopler T. Low holotranscobalamin II is the earliest serum marker for subnormal vitamin B12 (cobalamin) absorption in patients with AIDS. Am J Hematol 1990; 34: 1329.
  • 16
    Ulleland M, Eilertsen I, Quadros EV et al. Direct assay for cobalamin bound to transcobalamin (holotranscobalamin) in serum. Clin Chem 2002; 48: 4079.
  • 17
    Nexo E, Christensen AL, Hvas AM, Petersen TE, Fedosov SN. Quantitation of holo-transcobalamin, a marker of vitamin B12 deficiency. Clin Chem 2002; 48: 5612.
  • 18
    Hvas AM, Ellegaard J, Nexø E. Increased plasma methylmalonic acid does not predict clinical manifestations of vitamin B-12 deficiency. Arch Intern Med 2001; 161: 153441.
  • 19
    The European Agency for the Evaluation of Medicinal Products. Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95). London: The European Agency for the Evaluation of Medicinal Products, 1997.
  • 20
    Loikas S, Lopponen M, Suominen P et al. RIA for serum holo-transcobalamin: method evaluation in the clinical laboratory and reference interval. Clin Chem 2003; 49: 45562.
  • 21
    Nexo E, Christensen AL, Petersen TE, Fedosov SN. Measurement of transcobalamin by ELISA. Clin Chem 2000; 46: 16439.
  • 22
    Rasmussen K. Solid-phase sample extraction for rapid determination of methylmalonic acid in serum and urine by a stable-isotope-dilution method. Clin Chem 1989; 35: 2604.
  • 23
    Rasmussen K, Moller J, Lyngbak M, Pedersen AM, Dybkjaer L. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996; 42: 6306.
  • 24
    Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 1988; 11: 2132.
  • 25
    Roos D. The vibration perception threshold in gastrectomized patients with low serum B-12. Acta Neurol Scand 1977; 56: 55162.
  • 26
    Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 47383.
  • 27
    Bjørner JB, Damsgaard MT, Watt T et al. Dansk Manual Til SF-36. København: Lif, 1997.
  • 28
    Hvas AM, Juul S, Nexø E, Ellegaard J. Vitamin B-12 treatment has limited effect on health related quality of life among individuals with elevated plasma methylmalonic acid: a randomized placebo-controlled study. J Intern Med 2003; 253: 14652.
  • 29
    Roth M, Tym E, Mountjoy CQ et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986; 149: 698709.
  • 30
    Lauritzen L. Occurrence and diagnosis of dementia and dementia accompanied by depression. PhD Thesis, University of Copenhagen, 1998.
  • 31
    Folstein MF, Folstein SE, McHugh PR. ‘‘Mini-mental state’’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 18998.
  • 32
    Nielsen H, Lolk A, Krag-Sørensen P. Normative data for eight neuropsychological tests, gathered from a random sample of Danes aged 64 to 83 years. Nordisk Psykologi 1995; 47: 24155.
  • 33
    Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index diagnostic validity. J Affect Disord 2001; 66: 15964.
  • 34
    Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P. The internal and external validity of the Major Depression Inventory in measuring severity of depressive states. Psychol Med 2003; 33: 3516.
  • 35
    Obeid R, Schorr H, Eckert R, Hermann W. Vitamin B12 status in the elderly as judged by available biochemical markers. Clin Chem 2004; 50: 23841.
  • 36
    Lindgren A. Elevated serum methylmalonic acid. How much comes from cobalamin deficiency and how much comes from the kidneys? Scand J Clin Lab Invest 2002; 62: 159.
  • 37
    Hermann W, Obeid R, Schorr H, Geisel J. Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med 2003; 41: 147888.
  • 38
    Lloyd-Wright Z, Hvas AM, Møller J, Sanders TAB, Nexø E. Holotranscobalamin as an indicator of dietary vitamin B12 deficiency. Clin Chem 2003; 49: 20768.